Bovine serum albumin (BSA) and cleaved-BSA conjugated ultrasmall Gd2O3 nanoparticles: Synthesis, characterization, and application to MRI contrast agents

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 450, Issue 1, 2014, Pages 67-75

  Ahmad, Md Wasi ^a   Kim, Cho Rong ^a   Baeck, Jong Su ^a   Chang, Yongmin ^a   Kim, Tae Jeong ^a   Bae, Ji Eun ^a   Chae, Kwon Seok ^a   Lee, Gang Ho ^a  

^a Kyungpook National University   (South Korea)

Author keywords

BSA; C BSA; Contrast agent; MRI; Nanoparticle carrier; Ultrasmall Gd2O3 nanoparticle

Indexed keywords

BIOLOGICAL MOLECULE; BIOMEDICAL APPLICATIONS; BOVINE SERUM ALBUMINS; BSA; C-BSA; CONTRAST AGENT; CONTRAST ENHANCEMENT; ULTRA-SMALL;

BODY FLUIDS; MAGNETIC RESONANCE IMAGING; MAMMALS; MEDICAL APPLICATIONS; NANOPARTICLES;

SYNTHESIS (CHEMICAL);

BOVINE SERUM ALBUMIN; CARBROMAL; GADOLINIUM OXIDE; MACROGOL; NANOCOATING; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CRYSTAL STRUCTURE; CYTOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYNTHESIS;

EID: 84897862379     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2014.03.011     Document Type: Article

References (37)

1. Ackerson C.J., Jadzinsky P.D., Kornberg R.D. Thiolate ligands for synthesis of water-soluble gold clusters. J. Am. Chem. Soc. 2005, 127:6550-6551.
2. Sperling R.A., Parak W.J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos. Trans. R. Soc. A 2010, 368:1333-1383.
3. Martin V.V., Ralston W.H., Hynes M.R., Keana J.F.W. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents. Bioconjug. Chem. 1995, 6:616-623.
4. Nagaraja T.N., Croxen R.L., Panda S., Knight R.A., Keenan K.A., Brown S.L., Fenstermacher J.D., Ewing J.R. Application of arsenzo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent. J. Neurosci. Methods 2006, 157:238-245.
5. Lauffer R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 1987, 87:901-927.
6. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 1999, 99:2293-2352.
7. 2 MRI contrast agents. Phys. Chem. Chem. Phys. 2012, 14:12687-12700.
8. Kim T.J., Chae K.S., Chang Y., Lee G.H. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents. Curr. Top. Med. Chem. 2013, 13:422-433.
9. 1 MRI-CT dual contrast agent. Eur. J. Inorg. Chem. 2013, 2858-2866.
10. McDonald M.A., Watkin K.L. Small particulate gadolinium oxide and gadolinium oxide albumin microspheres as multimodal contrast and therapeutic agents. Invest. Radiol. 2003, 38:305-310.
11. Bloem J.L., Wondergem J. Gd-DTPA as a contrast agent in CT. Radiology 1989, 171:578-579.
12. Kawano T., Ishijima H., Nakajima T., Aoki J., Endo K. Gd-DTPA: a possible alternative contrast agent for use in CT during intraarterial administration. J. Comput. Assist. Tomogr. 1999, 23:939-940.
13. Bridot J.-L., Dayde D., Riviere C., Mandon C., Billotey C., Lerondel S., Sabattier R., Cartron G., Pape A.L., Blondiaux G., Janier M., Perriat P., Roux S., Tillement O. Hybrid gadolinium oxide nanoparticles combining imaging and therapy. J. Mater. Chem. 2009, 19:2328-2335.
14. De Stasio G., Rajesh D., Casalbore P., Daniels M.J., Erhardt R.J., Frazer B.H., Wiese L.M., Richter K.L., Sonderegger B.R., Gilbert B., Schaub S., Cannara R.J., Crawford J.F., Gilles M.K., Tyliszczak T., Fowler J.F., Larocca L.M., Howard S.P., Mercanti D., Mehta M.P., Pallini R. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?. Neurol. Res. 2005, 27:387-398.
15. De Stasio G., Casalbore P., Pallini R., Gilbert B., Sanita F., Ciotti M.T., Rosi G., Festinesi A., Larocca L.M., Rinelli A., Perret D., Mogk D.W., Perfetti P., Mehta M.P., Mercanti D. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res. 2001, 61:4272-4277.
16. Gierga D.P., Yanch J.C., Shefer R.E. An investigation of the feasibility of gadolinium for neutron capture synovectomy. Med. Phys. 2000, 27:1685-1692.
17. Lauffer R.B., Brady T.J. Preparation and water relaxation properties of protein labeled with paramagnetic metal chelates. Magn. Reson. Imaging 1985, 3:11-16.
18. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
19. Chen J., Wan R., Liu H., Cheng C.-M., Zhao Y.-F. Cleavage of BSA by a dipeptide seryl-histidine. Lett. Pept. Sci. 2001, 7:325-329.
20. 1 magnetic resonance imaging (MRI)-cell labeling (CL) dual agents. RSC Adv. 2012, 2:10907-10915.
21. Cao H., Xu S.-Y. EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation. J. Mater. Sci.: Mater. Med. 2008, 19:567-575.
22. 3 nanocrystals functionalized by organic acids. J. Colloid Interface Sci. 2005, 288:140-148.
23. Parca L., Gherardini P.F., Helmer-Citterich M., Ausiello G. Phosphate binding sites identification in protein structures. Nucleic Acids Res. 2011, 39:1231-1242.
24. Hirsch A.K.H., Fischer F.R., Diederich F. Phosphate recognition in structural biology. Angew. Chem. Int. Ed. 2007, 46:338-352.
25. - by a cholestane-imidazole-zinc ensemble. Tetrahedron Lett. 2012, 53:2627-2631.
26. JCPDS card number 32-0386 for GdPO4, PCPDFWIN, Version 2.4, 2003.
27. 2. Phys. Chem. Chem. Phys. 2006, 8:3232-3247.
28. 6 dicarboxylic acids at pH=5.0. Geochim. Cosmochim. Acta 2001, 65:4289-4301.
29. Hug S.J., Bahnemann D. Infrared spectra of oxalate, malonate and succinate adsorbed on the aqueous surface of rutile, anatase and lepidocrocite measured with in situ ATR-FTIR. J. Electron Spectrosc. Relat. Phenom. 2006, 150:208-219.
30. 2 in the aqueous phase. Langmuir 1994, 10:3587-3597.
31. Xu X., Zhang J.-F., Fan Y. Fabrication of cross-linked polyethyleneimine microfibers by reactive electrospinning with in situ photo-cross-linking by UV radiation. Biomacromolecules 2010, 11:2283-2289.
32. Yudovin-Farber I., Beyth N., Weiss E.I., Domb A.J. Antibacterial effect of composite resins containing quaternary ammonium polyethyleneimine nanoparticles. J. Nanopart. Res. 2010, 12:591-603.
33. Liu C., Zhang P., Zhai X., Tian F., Li W., Yang J., Liu Y., Wang H., Wang W., Liu W. Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence. Biomaterials 2012, 33:3604-3613.
34. Weast R.C. CRC Handbook of Chemistry and Physics 1984-1985, B-96. CRC Press Inc., Boca Raton, FL. 65th ed.
35. Reed R.G., Putnam F.W., Peters T. Sequence of residues 400-403 of bovine serum albumin. Biochem. J. 1980, 191:867-868.
36. Weijers R.N.M. Amino acid sequence in bovine serum albumin. Clin. Chem. 1977, 23:1361-1362.
37. 3 (Ln=Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent. ACS Appl. Mater. Interfaces 2011, 3:3325-3334.